Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-16-092943

Director sold 15,000 shares at $14.51 ($217,650)

  • Director acquired 15,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Lingnau Lutz · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2016-01-20 Exercise or conversion : show line 1 in the form +15,000 $5.15 $77,250 31,450 D
2016-01-20 Sale : show line 2 in the form −15,000 $14.51 $217,650 16,450 D
Open-market sales · 15,000 sh · avg $14.51 · $217,650

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2016-01-20 Exercise or conversion : show line 3 in the form Stock Option −15,000 $5.15 2016-12-01 15,000 0 D
Loading xslF345X03/doc4.xml…